Recombinant human monoclonal antibody expressed in CHO binding to human cytomegalovirus glycoprotein B. Regavirumab is a human monoclonal antibody against cytomegalovirus infections.
Figure 1 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in SDS-PAGE
SDS-PAGE analysis of TAB-894 in non-reduced (Lane 1) and reduced (Lane 2) conditions.
Figure 2 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in HPLC
HPLC analysis of TAB-894 shows the purity is>95%.
Figure 3 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in ELISA
ELISA analysis of TAB-894 was performed by coating with Human cytomegalovirus (HCMV) Glycoprotein B.
The secondary antibody: Goat Anti-Human IgG(H+L)-HRP
Figure 4 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in WB
Western blot analysis of TAB-894 was performed with Human cytomegalovirus (HCMV) Glycoprotein B.
TAB-894 incubation concentration: 2ng/μL.
The secondary antibody: Goat Anti-Human IgG(H+L)-HRP
Lane 1: Reducing Antigen (0.1μg)
Lane 2: Reducing Antigen (0.3μg)
Lane 3: Reducing Antigen (0.6μg)
Figure 5 Anti-Human Cytomegalovirus Glycoprotein B Recombinant Antibody (Regavirumab) (TAB-894) in DB
Dot Blot analysis of TAB-894 was performed by coating with Human cytomegalovirus (HCMV) Glycoprotein B.
TAB-894 incubation concentration: 2ng/μL.
The secondary antibody: Goat Anti-Human IgG(H+L)-HRP
NC: Negative control PC: Positive control
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-HCMV ADCC Recombinant Antibody (Regavirumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human cytomegalovirus glycoprotein B. Regavirumab is a human monoclonal antibody against cytomegalovirus infections.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-1186-VHH | Recombinant Anti-HCMV VHH Single Domain Antibody | IHC, ICC, IP, ChiP, Neut | Llama VHH |
There are currently no Customer reviews or questions for TAB-894. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.